High frequency of gastrointestinal complaints, but insignificant prevalence of gluten-sensitive enteropathies in Brazilian fibromyalgia patients

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER ESPANA SLU
Citação
REUMATOLOGIA CLINICA, v.19, n.7, p.374-378, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction/Objectives: Coeliac disease (CD) and non-coeliac gluten sensitivity (NCGS) cause symptoms like those seen in patients with fibromyalgia (FM) and functional gastrointestinal disorders. There is no consistent data on frequency of these symptoms and no study performed duodenal biopsies to investigate CD/NCGS in Brazilian FM patients. Therefore, we sought to verify the prevalence of CD/NCGS in FM patients and the association between gastrointestinal manifestations and FM symptoms.Material and methods: Sixty-two individuals with FM (ACR2010) were recruited from FM outpatient clinics of a tertiary hospital. Clinical evaluation included the Widespread Pain Index (WPI), Severity Symptom Scale (SS), Polysymptomatic Distress Scale (PDS), and Fibromyalgia Impact Questionnaire (FIQ). Subjects were screened for the presence of coeliac antibodies and upper gastrointestinal endoscopy (duodenal biopsies) was performed for diagnosis of CD/NCGS.Results: 46 (74.2%) women reported at least one digestive symptom: constipation, abdominal distension, loss of weight/inappetence, and nausea/vomiting. Fourteen (31.8%) presented macroscopic duodenitis and 2(4.5%) had duodenal lymphocytic infiltrates, but none met CD criteria. In 1(1.6%) patient NCGS was confirmed. There was association between presence of any digestive symptom and WPI and SS (fatigue, waking up tired, cognition), but no difference on FIQ between patients with and without gastrointestinal symptoms.Conclusion: Gastrointestinal complaints were frequent and associated with increased degree of polysymptomatic distress in FM patients, but presence of these symptoms was not related to overall impact of FM over different dimensions of the patient's life. Moreover, the prevalence of CD/NCGS was very low. This suggests that screening for CD in Brazilian FM patients might not be cost-effective, since the frequency of CD/NCGS was very low.& COPY; 2022 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologi & PRIME;a y Colegio Mexicano de Reumatologi & PRIME;a. All rights reserved.
Palavras-chave
Fibromyalgia, Coeliac disease, Gastrointestinal, Gluten sensitivity, Duodenitis
Referências
  1. Almansa C, 2009, CLIN GASTROENTEROL H, V7, P438, DOI 10.1016/j.cgh.2008.12.005
  2. Arnold LM, 2011, MAYO CLIN PROC, V86, P457, DOI 10.4065/mcp.2010.0738
  3. Barbaro MR, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123735
  4. Caio G, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1380-z
  5. Crowe SE, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-9-201105030-01005
  6. Erdrich S, 2020, THER ADV GASTROENTER, V13, DOI 10.1177/1756284820977402
  7. Cárdenas-Torres FI, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060526
  8. Leonard MM, 2021, GASTROENTEROLOGY, V160, P437, DOI 10.1053/j.gastro.2020.08.061
  9. Losurdo G, 2018, WORLD J GASTROENTERO, V24, P1521, DOI 10.3748/wjg.v24.i14.1521
  10. Lupi JB, 2017, DISABIL REHABIL, V39, P1650, DOI 10.1080/09638288.2016.1207106
  11. MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P
  12. García-Leiva JM, 2015, RHEUMATOL INT, V35, P561, DOI 10.1007/s00296-014-3110-3
  13. Nisihara R, 2016, REV ESP ENFERM DIG, V108, P107
  14. Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019
  15. Paiva ES, 2013, CLIN RHEUMATOL, V32, P1199, DOI 10.1007/s10067-013-2259-6
  16. Rodrigo L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0421-4
  17. Rodrigo L, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4391
  18. Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79
  19. Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13
  20. Slim M, 2015, RHEUMATOL INT, V35, P433, DOI 10.1007/s00296-014-3109-9
  21. Tovoli F, 2013, CLIN EXP RHEUMATOL, V31, pS50
  22. TRIADAFILOPOULOS G, 1991, DIGEST DIS SCI, V36, P59, DOI 10.1007/BF01300088
  23. Wolfe F, 2016, SEMIN ARTHRITIS RHEU, V46, P319, DOI 10.1016/j.semarthrit.2016.08.012
  24. Wolfe F, 2016, J RHEUMATOL, V43, P454, DOI 10.3899/jrheum.150926
  25. Zipser RD, 2003, DIGEST DIS SCI, V48, P761, DOI 10.1023/A:1022897028030